Fidaxomicin-Use-Rose-Significantly-Following-CDI-Guideline-Update

Originally published by our sister publication Infectious Disease Special EditionBy Ethan CoveyFidaxomicin use is markedly increasing for treating Clostridioides difficile infection (CDI), according to a study presented at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas.figure img { width:100% !important; } figcaption { padding: 5px; background: transparent; word-wrap: normal; text-align: center; font-size:10px; line-height: 12px; }Source: Adobe Stock.The new an analysis of